Sands Capital Ventures
$614M 13F equity value
24 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Sands Capital Ventures covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ALMR | ALAMAR BIOSCIENCES INC | 4,230,926 | $115M | 18.7% |
| NU | NU HLDGS LTD | 7,094,952 | $95M | 15.4% |
| KVYO | KLAVIYO INC | 3,928,146 | $59M | 9.7% |
| BBNX | BETA BIONICS INC | 3,708,043 | $58M | 9.5% |
| SGP | SPYGLASS PHARMA INC | 2,500,012 | $56M | 9.1% |
| IKT | INHIBIKASE THERAPEUTICS INC | 13,018,965 | $26M | 4.3% |
| DASH | DOORDASH INC | 127,562 | $24M | 3.8% |
| CPNG | COUPANG INC | 1,329,314 | $23M | 3.8% |
| DDOG | DATADOG INC | 80,851 | $21M | 3.4% |
| BIOA | BIOAGE LABS INC | 786,353 | $19M | 3.1% |
Track Sands Capital Ventures's 13F portfolio: $614M in reported holdings, 24 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}